IR
IRCCS San Raffaele
NPMilan ITFounded 19715,000 employees
Private CapacadPrivateOncologyNeurology
Platform: Research Hosp
Market Cap
N/A
All Drugs
3
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| IRC-IIT-265 | IRC-IIT-265 | Phase 1/2 | 1 | CD123 | Angelman | ||
| IRC-IIT-214 | IRC-IIT-214 | Phase 2 | 1 | CD47 | Rett | ||
| IRC-IIT-452 | IRC-IIT-452 | Phase 1 | 1 | TNFα | Gastric Ca |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (4)